Please ensure Javascript is enabled for purposes of website accessibility
ホーム > 製品 > 抗体 > バイオシミラー

Anti-Human CD28 Reference Antibody (Pegrizeprument, RUO) (HY422056)

Anti-Human CD28 Reference Antibody (Pegrizeprument, RUO)
Anti-Human CD28 Reference Antibody (Pegrizeprument, RUO)
Anti-Human CD28 Reference Antibody (Pegrizeprument, RUO)
Anti-Human CD28 Reference Antibody (Pegrizeprument, RUO)
価格(USD):
スペック:
  • 100ug
  • 1mg
  • 5mg
  • 10mg
  • 25mg
  • 50mg
  • 100mg
数量:
お問い合わせ
  • 概要

  • イメージ

  • 参考文献

  • データシート

  • SDS

概要
カタログ番号HY422056
説明
Pegrizeprument (HY422056) is a research-grade recombinant antibody targeting CD28. Produced in mammalian cells with native-like glycosylation.
Highlights
  • ●Research Grade — For PK/PD studies, assay development, and ADA research.
  • ●Native Glycosylation — Mammalian expression ensures native-like patterns.
種反応性Human
アプリケーションELISA, Bioactivity: FACS, Functional assay, Research in vivo, WB
宿主種Chimeric
クローン性Monoclonal
アイソタイプImmunoglobulin Fab VH-G1CH1h_L-kappa
発現システム Mammalian cells
テスト済みアプリケーション WB
ターゲット CD28, TP44, T-cell-specific surface glycoprotein CD28
エンドトキシンレベル < 10 EU/mg
純度 >95% purity as determined by SDS-PAGE.
精製 Protein A/G purified from cell culture supernatant.
アクセッション番号 P10747
形態 Liquid
保存バッファー 0.01M PBS pH 7.4

データシートのハードコピーまたはロット固有のCOAに記載された具体的なバッファー情報を参照してください。

製品使用情報
アプリケーション 希釈
WB 1:500-1:2000
安定性と保存 Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt.
別名2829316-24-5
背景

T-cell-specific surface glycoprotein CD28 is a ~25 kDa protein. Receptor that plays a role in T-cell activation, proliferation, survival and the maintenance of immune homeostasis. Functions not only as an amplifier of TCR signals but delivers unique signals that control intracellular biochemical events that alter the gene expression program of T-cells. Stimulation upon engagement of its cognate ligands CD80 or CD86 increases proliferation and expression of various cytokines in particular IL2 production in both CD4(+) and CD8(+) T-cell subsets. Mechanistically, ligation induces recruitment of protein kinase C-theta/PRKCQ and GRB2 leading to NF-kappa-B activation via both PI3K/Akt-dependent and -independent pathways. In conjunction with TCR/CD3 ligation and CD40L costimulation, enhances the production of IL4 and IL10 in T-cells.

1. Gimmi, CD. et al. (1991) Proceedings of the National Academy of Sciences of the United States of America 88, 6575-9. PMID: 1650475
2. Raab, M. et al. (1995) Proceedings of the National Academy of Sciences of the United States of America 92, 8891-5. PMID: 7568038
3. Skånland, SS. et al. (2014) The Biochemical journal 460, 399-410. PMID: 24665965
4. Collins, AV. et al. (2002) Immunity 17, 201-10. PMID: 12196291
5. Wu, H. et al. (2022) Structure (London, England : 1993) 30, 803-812.e5. PMID: 35397202
6. Kong, KF. et al. (2011) Nature immunology 12, 1105-12. PMID: 21964608
7. Blotta, MH. et al. (1996) Journal of immunology (Baltimore, Md. : 1950) 156, 3133-40. PMID: 8617933
注意事項 For research use only. Not suitable for clinical or therapeutic use.
イメージ
  • Anti-Human CD28 Reference Antibody (Pegrizeprument, RUO)

    SDS-PAGE

    SDS-PAGE for Research Grade Pegrizeprument.

  • Anti-Human CD28 Reference Antibody (Pegrizeprument, RUO)

    Western blot

    Western blot analysis was performed using anti-CD28 monoclonal antibody at 1ug/mL on various samples.
    Lane 1: recombinant human CD28 (Catalog No: HY422011)
    Lane 2: Negative control

参考文献
Formula
Mass (g) = Concentration (mol/L) × Volume (L) × MW (g/mol)
Enter any 2 of Mass, Concentration, Volume + Molecular Weight to solve for the unknown.
Mass
=
Concentration
×
Volume
Molecular Weight *
g/mol
Formula
C₁ × V₁ = C₂ × V₂
Enter any 3 of the 4 values to solve for the unknown.
Stock Solution
C₁ (Stock Conc.)
×
V₁ (Stock Vol.)
=
Working Solution
C₂ (Working Conc.)
×
V₂ (Working Vol.)
レコメンデーション

お問い合わせ カスタムクォート、大量リクエストおよびその他の問題については

メール: [email protected]

ディストリビューターリスト